S&P 500
(0.12%) 5 303.27 points
Dow Jones
(0.34%) 40 004 points
Nasdaq
(-0.07%) 16 686 points
Oil
(0.97%) $80.00
Gas
(5.73%) $2.64
Gold
(1.44%) $2 419.80
Silver
(6.36%) $31.78
Platinum
(2.18%) $1 094.70
USD/EUR
(-0.02%) $0.920
USD/NOK
(-0.18%) $10.68
USD/GBP
(-0.27%) $0.787
USD/RUB
(0.19%) $91.05

Realtime updates for Biophytis SA [ALBPS.PA]

Exchange: EURONEXT Industry: Biotechnology
Last Updated17 May 2024 @ 11:35

1.04% 0.800

Live Chart Being Loaded With Signals

Commentary (17 May 2024 @ 11:35):

Biophytis S.A., a clinical-stage biotechnology company, focuses on the development of therapeutics that slow the degenerative processes and improve functional outcomes for patients suffering from age-related diseases...

Stats
Today's Volume 13 125.00
Average Volume 63 562.00
Market Cap 2.80M
EPS €0 ( 2024-04-14 )
Last Dividend €0 ( N/A )
Next Dividend €0 ( N/A )
P/E -0.0700
ATR14 €0.00600 (0.77%)

Volume Correlation

Long: 0.14 (neutral)
Short: -1.00 (very strong negative)
Signal:(43.142) Neutral

Biophytis SA Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Biophytis SA Correlation - Currency/Commodity

The country flag 0.01
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag -0.14
( neutral )

Biophytis SA Financials

Annual 2023
Revenue: €0
Gross Profit: €-803 000 (0.00 %)
EPS: €-12.54
FY 2023
Revenue: €0
Gross Profit: €-803 000 (0.00 %)
EPS: €-12.54
FY 2022
Revenue: €0
Gross Profit: €-484 000 (0.00 %)
EPS: €-0.130
FY 2021
Revenue: €0.00
Gross Profit: €0.00 (0.00 %)
EPS: €-0.260

Financial Reports:

No articles found.

Biophytis SA Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Biophytis SA

Biophytis S.A., a clinical-stage biotechnology company, focuses on the development of therapeutics that slow the degenerative processes and improve functional outcomes for patients suffering from age-related diseases. Its therapeutics focuses on targeting and activating key biological resilience pathways that could protect against and counteract the effects of the multiple biological and environmental stresses that lead to age-related diseases. The company's lead drug candidate is Sarconeos (BIO101), an orally administered small molecule in development for the treatment of neuromuscular diseases, including sarcopenia and Duchenne muscular dystrophy (DMD), as well as in Phase 2/3 clinical study for the treatment of severe respiratory failure in patients suffering from COVID-19. It also develops Macuneos (BIO201), an orally administered small molecule for the treatment of retinal diseases, including dry age-related macular degeneration (AMD) and Stargardt disease. Biophytis SA has a collaboration agreement with AFM-Telethon for the development of its Sarconeos (BIO101) for the treatment of DMD. The company was incorporated in 2006 and is headquartered in Paris, France.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators